EFFECTS OF VITAMIN B1 IN SCHIZOPHRENIA
Abstract
1. Ten schizophrenic male patients were given large doses of synthetic vitamin B1 orally and intravenously for a period of eight weeks.
2. None showed clinical improvement that could be correlated with the medication. No deleterious effects were seen.
3. The Stanford-Binet scores showed only random changes.
4. No significant changes were observed in blood pressure, pulse rate, oxygen consumption rate, venous carbon dioxide and glutathione levels.
5. Decreases in venous oxygen and lactic acid levels were observed.
6. Three patients were given in addition four weekly injections of vitamin B1 intrathecally without significant effects.
7. Extension of the study with other catalytic agents is regarded as desirable.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
